Cover Image
市场调查报告书

Ioversol的中国市场

Investigation Report on Chinese Ioversol Market, 2018-2022

出版商 China Research and Intelligence 商品编码 338989
出版日期 内容信息 英文 30 Pages
商品交期: 最快1-2个工作天内
价格
Back to Top
Ioversol的中国市场 Investigation Report on Chinese Ioversol Market, 2018-2022
出版日期: 2018年07月05日 内容信息: 英文 30 Pages
简介

Ioversol为非离子系的显影剂,由于毒性很低对人体没有影响,用于影像诊断时的血管造影。随著X光扫描、CT、超音波、MRI检验的利用数量增加,含Ioversol的血管显影剂市场正在急速扩大。中国国内的Ioversol的销售额,2005年为3000万人民币,2014年为2亿人民币,以27%年复合成长率(CAGR) 增加。

本报告提供中国的Ioversol的市场相关分析、Ioversol的特徵和认证情形、市场整体规模、各企业/各剂型的市场占有率、价格趋势、主要制造商简介、今后的市场成长预测等调查评估。

第1章 Ioversol的相关概念

  • 适应症
  • 全球市场的销售情形

第2章 中国的Ioversol市场简介

  • 中国国内的Ioversol的专利申请、核准情况
  • 主要制造商
  • 市场规模

第3章 中国国内的Ioversol销售额分析 (过去5年份)

  • 销售额
    • 整体销售额
    • 各地区的销售额
  • 销售量
    • 整体销售量
    • 各地区的销售量

第4章 Ioversol的主要厂商的市场占有率 (过去5年份)

  • 市场占有率 (以金额为准)
  • 市场占有率 (以数量为准)

第5章 中国国内的Ioversol的剂型 (过去5年份)

  • 各剂型的市场占有率 (以金额为准)
  • 各剂型的市场占有率 (以数量为准)

第6章 中国医院的Ioversol的参照价格

  • Jiangsu Hengrui Medicine Co., Ltd
  • Mallinckrodt Medical Inc. (加拿大)
  • Mallinckrodt Medical Inc. (美国)

第7章 中国国内的Ioversol的主要制造商 (过去5年份)

  • Jiangsu Hengrui Medicine Co., Ltd
  • Mallinckrodt Medical Inc. (美国)

第8章 中国国内的Ioversol市场未来展望 (今后5年份)

  • 市场规模的预测
  • 竞争环境的预测

图表一览

本网页内容可能与最新版本有所差异。详细情况请与我们联系。

目录
Product Code: 1806300

Description

Contract media are chemical products that are injected into or taken by human tissues or organs to improve image observation. The global contrast media market is growing continuously with higher demand for medical exam accuracy and increasing popularity of angiography.

Ioversol is a new-type non-ionic contrast agent mainly used in contrast-enhanced vascular imaging, featured by high contract density, avirulence, high tolerance and few side effects. After Ioversol is injected to blood vessels, the high proportion of iodine can cause x-ray attenuation and clearly show the blood vessels till Ioversol is diluted.

Contrast media are among the most common drugs in interventional radiology practice. They are mainly used to show blood vessels and coeloms. With large growth momentum and potential, the applications of contrast media have gradually extended from x-ray photography/CT scan imaging to diagnoses and examinations such as ultrasonography and magnetic resonance angiography. Ioversol has been widely used in China. As the number of the diagnosed continues to rise, the Ioversol market will continue to grow in China.

With China's growing demand for Ioversol, the sales value exceeded CNY 400 million in 2017. According to CRI, Jiangsu Hengrui, Liebel-Flarsheim and Mallinckrodt accounted for the major shares of the Chinese Ioversol market. By sales value, the market share of Jiangsu Hengrui exceeded 90% in 2017.

Topics Covered:

  • Development history of Ioversol in China
  • Size of China Ioversol market
  • Competition Pattern of Chinese Ioversol market
  • Prices in the Chinese Ioversol market
  • Prospects of Chinese Ioversol Market, 2018-2022

Table of Contents

Table of Contents

1 Relevant Concepts of Ioversol

  • 1.1 Indications
  • 1.2 Development History of Ioversol in China
  • 1.3 Production Permit of Ioversol in China

2 Investigation on Sales of Ioversol in China, 2013-2017

  • 2.1 Sales Value of Ioversol in China
    • 2.1.1 Overall Sales Value
    • 2.1.2 Sales Value in Different Regions
  • 2.2 Sales Volume of Ioversol in China
    • 2.2.1 Overall Sales Volume
    • 2.2.2 Sales Volume in Different Regions
  • 2.3 Sales of Ioversol in Different Dosage Forms in China
    • 2.3.1 Market Share of Ioversol in Different Dosage Forms by Sales Value
    • 2.3.2 Market Share of Ioversol in Different Dosage Forms by Sales Volume

3 Investigation on Market Share of Major Ioversol Manufacturers in China, 2013-2017

  • 3.1 Analysis on Market Competition of Ioversol in China, 2013-2017
    • 3.1.1 Major Manufacturers
    • 3.1.2 Market Share by Sales Value
    • 3.1.3 Market Share by Sales Volume
  • 3.2 Jiangsu Hengrui Medicine Co., Ltd.
    • 3.2.1 Profile of Jiangsu Hengrui Medicine Co., Ltd.
    • 3.2.2 Sales of Jiangsu Hengrui's Ioversol
    • 3.2.3 Sales Price of Jiangsu Hengrui's Ioversol
  • 3.3 Liebel-Flarsheim
  • 3.4 Mallinckrodt

4 Prospects of Chinese Ioversol Market, 2018-2022

  • 4.1 Forecast on Market Size
  • 4.2 Forecast on Competition Pattern

Selected Charts

  • Chart Production Permit of Ioversol in China
  • Chart Sales of Ioversol in China
  • Chart Sales Value of Ioversol in China, 2007-2017
  • Chart Sales Value of Ioversol in Parts of China, 2013-2017
  • Chart Sales Volume of Ioversol in China, 2007-2017
  • Chart Sales Volume of Ioversol in Parts of China, 2013-2017
  • Chart Market Share and Sales Value of Jiangsu Hengrui's Ioversol in China, 2013-2017
  • Chart Market Share and Sales Value of Liebel-Flarsheim's Ioversol in China, 2013-2017
  • Chart Market Share and Sales Value of Mallinckrodt's Ioversol in China, 2013-2017
  • Chart Sales Value and Market Share of Ioversol Injections in China, 2013-2017
  • Chart Prices of Jiangsu Hengrui's Ioversol in Several Chinese Cities, 2017-2018
  • Chart Prices of Mallinckrodt's Ioversol in Several Chinese Cities, 2017-2018
  • Chart Forecast on Ioversol's Sales in China, 2018-2022
Back to Top